Literature DB >> 6206492

Differential DNase I sensitivity of the albumin and alpha-fetoprotein genes in chromatin from rat tissues and cell lines.

J L Nahon, A Gal, T Erdos, J M Sala-Trepat.   

Abstract

We have examined the DNase I sensitivity of the albumin and alpha-fetoprotein (AFP) genes in different rat tissues (adult liver and kidney) and cloned cell lines (hepatoma 7777-C8, JF1 fibroblasts), which show drastic differences in the level of expression of these two genes. This was done by studying the disappearance of defined restriction endonuclease fragments of these genes as a function of limited DNase I digestion. The sensitivity of these genes was compared to that of a gene not expressed in the hepatic cells and to that of a ubiquitously expressed gene. In nuclei from adult rat liver the albumin and AFP genes were preferentially degraded by the nucleolytic action of DNase I, whereas they were not in rat kidney nuclei. In the hepatoma cells the AFP gene was much more sensitive to DNase I digestion than the albumin gene; both genes were very resistant to DNase I action in fibroblastic nuclei. When analyzed in relation to the level of gene expression our results indicate that alterations in the chromatin structure of the albumin and AFP genes might be involved in the early establishment of the tissue-specific potential of overt gene expression; such alterations reflected in an altered DNase I sensitivity do not appear to be responsible for the changes in gene activity occurring during the terminal differentiation of the hepatocyte; and modifications in the chromatin structure of these genes might occur during oncogenic events; these structural modifications could be related to the changes in gene expression observed in hepatocarcinogenic processes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206492      PMCID: PMC391631          DOI: 10.1073/pnas.81.16.5031

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Chromosomal subunits in active genes have an altered conformation.

Authors:  H Weintraub; M Groudine
Journal:  Science       Date:  1976-09-03       Impact factor: 47.728

3.  The calcium dependent endonuclease activity of isolated nuclear preparations. Relationships between its occurrence and the occurrence of other classes of enzymes found in nuclear preparations.

Authors:  D R Hewish; L A Burgoyne
Journal:  Biochem Biophys Res Commun       Date:  1973-05-15       Impact factor: 3.575

Review 4.  Alpha-fetoprotein in ontogenesis and its association with malignant tumors.

Authors:  G I Abelev
Journal:  Adv Cancer Res       Date:  1971       Impact factor: 6.242

5.  Synthesis of serum albumin, prealbumin, alpha-foetoprotein, alpha-1-antitrypsin and transferrin by the human yolk sac.

Authors:  D Gitlin; A Perricelli
Journal:  Nature       Date:  1970-12-05       Impact factor: 49.962

6.  Temporal order of chromatin structural changes associated with activation of the major chicken vitellogenin gene.

Authors:  J B Burch; H Weintraub
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

7.  alpha-Fetoprotein and albumin genes of rats: no evidence for amplification-deletion or rearrangement in rat liver carcinogenesis.

Authors:  J M Sala-Trepat; T D Sargent; S Sell; J Bonner
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

8.  Changes in expression of albumin and alpha-fetoprotein genes during rat liver development and neoplasia.

Authors:  J M Sala-Trepat; J Dever; T D Sargent; K Thomas; S Sell; J Bonner
Journal:  Biochemistry       Date:  1979-05-29       Impact factor: 3.162

9.  Expression of an oncodevelopmental gene product (alpha-fetoprotein) during fetal development and adult oncogenesis.

Authors:  S Sell; F F Becker; H L Leffert; L Watabe
Journal:  Cancer Res       Date:  1976-11       Impact factor: 12.701

10.  Structural variants of the alpha-fetoprotein gene in different inbred strains of rat.

Authors:  A Gal; J L Nahon; G Lucotte; J M Sala-Trepat
Journal:  Mol Gen Genet       Date:  1984
View more
  6 in total

1.  DNase I-hypersensitive sites in the 5'-flanking region of the rat serum albumin gene: correlation between chromatin structure and transcriptional activity.

Authors:  L E Babiss; A Bennett; J M Friedman; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

2.  Developmental acquisition of DNase I sensitivity of the phosphoenolpyruvate carboxykinase (GTP) gene in rat liver.

Authors:  N Benvenisty; L Reshef
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

3.  Rat alpha 1-fetoprotein messenger RNA: 5'-end sequence and glucocorticoid-suppressed liver transcription in an improved nuclear run-off assay.

Authors:  B Turcotte; M Guertin; M Chevrette; L Bélanger
Journal:  Nucleic Acids Res       Date:  1985-04-11       Impact factor: 16.971

4.  Specific sets of DNase I-hypersensitive sites are associated with the potential and overt expression of the rat albumin and alpha-fetoprotein genes.

Authors:  J L Nahon; A Venetianer; J M Sala-Trepat
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

5.  Albumin and alpha-fetoprotein gene transcription in rat hepatoma cell lines is correlated with specific DNA hypomethylation and altered chromatin structure in the 5' region.

Authors:  I Tratner; J L Nahon; J M Sala-Trepat; A Venetianer
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

6.  DNase I hypersensitivity and methylation of the 5'-flanking region of the alpha 1-fetoprotein gene during developmental and glucocorticoid-induced repression of its activity in rat liver.

Authors:  B Turcotte; M Guertin; M Chevrette; H LaRue; L Bélanger
Journal:  Nucleic Acids Res       Date:  1986-12-22       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.